Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Shallow Nanopore sequencing reveals genomic and epigenomic signatures of circulating tumor DNA in neuroendocrine tumor patients

Wednesday, February 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented at CNAPS 2025 discusses the prognostic value of circulating H3K27Me3-nucleosomes in newly diagnosed lung cancer patients. This research highlights the potential of Shallow Nanopore sequencing to identify genomic and epigenomic signatures in circulating tumor DNA. The findings may contribute to advancements in cancer diagnostics and treatment planning.
Price reaction · baseline $5.446 (2026-02-03 close) · hit pre-market · 4 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-4.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • The research presents promising prognostic markers for lung cancer.
  • Utilization of Shallow Nanopore sequencing shows innovative approaches.
  • Findings may enhance early detection and treatment strategies.

Full Press Release Details

Poster titled: Prognostic Value of Circulating H3K27Me3-Nucleosomes In Newly Diagnosed Lung Cancer Patients
Benjamin P. Berman, Maria Ouzounova, Marie Piecyk, Christina Wheeler, Theresa K. Kelly, Lea Payen-Gay, Thomas Walter
Presented at CNAPS 2025

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at CNAPS 2025?

The poster discussed the prognostic value of circulating H3K27Me3-nucleosomes in lung cancer.

What technique was used in the research?

Shallow Nanopore sequencing was utilized to analyze circulating tumor DNA.

What is the significance of H3K27Me3-nucleosomes?

They serve as potential prognostic markers for newly diagnosed lung cancer patients.

How might this research impact cancer treatment?

It may enhance early detection and inform treatment strategies for lung cancer.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare lung cancer H3K27Me3 Shallow Nanopore sequencing genomic signatures
Last updated: Feb 4, 2026

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk